Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333:1172 (2 December), doi:10.1136/bmj.39045.403808.1F
| The first 150 words of the full text of this article appear below. |
My analysis was based on 206 studies (several million observations' worth of data) included in systematic reviews spanning some 40 years. The hypotheses by Mandl do not fit some of the evidence in the elderly population.1 He cannot explain how in years of good matching between vaccine antigenic content and circulating viruses the vaccines fail to prevent deaths from all respiratory diseases in elderly community dwellers (1.32, 95% confidence interval 1.25 to 1.39, 426 668 observations) while at the same time preventing 42% (25% to 55%, 404 759 observations) of deaths from all causes,2 presumably including deaths from falls, accidental poisoning, accidents, hypothermia, and so on.
Fedson and Nichol deride my choice of example of poor methodological quality of a large number of available cohort studies.1 The authors of the studies either did not know such details or like Fedson and Nichol thought them irrelevant and would leave a reader
Tom Jefferson, coordinator
1 Cochrane Vaccines Field, Anguillara Sabazia, Roma 00061, Italy jefferson.tom@gmail.com